Vivos (RDGL) Enterprise Value Growth (5y) (2015 - 2025)
Vivos (RDGL) Enterprise Value Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Vivos | 22.64 Mn | 21.08 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.52% |
| Sep 30, 2025 | -171.48% |
| Jun 30, 2025 | -60.62% |
| Dec 31, 2024 | -155.35% |
| Sep 30, 2024 | -50.35% |
| Jun 30, 2024 | -189.35% |
| Mar 31, 2024 | -100.99% |
| Dec 31, 2023 | -210.76% |
| Mar 31, 2023 | -875.37% |
| Dec 31, 2022 | -190.01% |
| Sep 30, 2022 | -145.90% |
| Jun 30, 2022 | -23.25% |
| Mar 31, 2022 | -120.01% |
| Dec 31, 2021 | -124.94% |
| Sep 30, 2021 | -957.80% |
| Jun 30, 2021 | -552.51% |
| Mar 31, 2021 | -58.90% |
| Dec 31, 2020 | -38.24% |
| Sep 30, 2020 | -15.09% |
| Jun 30, 2020 | -56.83% |